MilliporeSigma Opens China's First BioReliance End-to-End Biodevelopment Center In Shanghai Post author:Sam Post published:September 21, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>ConfirmMDx</b> Study Provides Further Validation Of Epigenetic Risk Profile August 9, 2017 Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process October 5, 2017 <b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017
Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process October 5, 2017
<b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017